Joseph Yeboah to Longitudinal Studies
This is a "connection" page, showing publications Joseph Yeboah has written about Longitudinal Studies.
Connection Strength
0.253
-
Yeboah J. Road to the American Heart Association 2020 Impact Goals: The Metric for Monitoring Progress. Circ Cardiovasc Imaging. 2018 01; 11(1):e007385.
Score: 0.134
-
Al Rifai M, Martin SS, McEvoy JW, Nasir K, Blankstein R, Yeboah J, Miedema M, Shea SJ, Polak JF, Ouyang P, Blumenthal RS, Bittencourt M, Bensenor I, Santos RD, Duncan BB, Santos IS, Lotufo PA, Blaha MJ. The prevalence and correlates of subclinical atherosclerosis among adults with low-density lipoprotein cholesterol <70?mg/dL: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Atherosclerosis. 2018 07; 274:61-66.
Score: 0.034
-
Kianoush S, Al Rifai M, Cainzos-Achirica M, Al-Mallah MH, Tison GH, Yeboah J, Miedema MD, Allison MA, Wong ND, DeFilippis AP, Longstreth W, Nasir K, Budoff MJ, Matsushita K, Blaha MJ. Thoracic extra-coronary calcification for the prediction of stroke: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2017 Dec; 267:61-67.
Score: 0.033
-
Ahmed FS, Jiang XC, Schwartz JE, Hoffman EA, Yeboah J, Shea S, Burkart KM, Barr RG. Plasma sphingomyelin and longitudinal change in percent emphysema on CT. The MESA lung study. Biomarkers. 2014 May; 19(3):207-13.
Score: 0.026
-
Manichaikul A, Rich SS, Perry H, Yeboah J, Law M, Davis M, Parker M, Ragosta M, Connelly JJ, McNamara CA, Taylor AM. A functionally significant polymorphism in ID3 is associated with human coronary pathology. PLoS One. 2014; 9(3):e90222.
Score: 0.026